Ferrer, Lanileah G.
HRN: 24-53-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2024
CEFUROXIME 1.5GM (VIAL)
04/01/2024
04/01/2024
IV
1.5grams
PTOR
For Diagnostic D&C
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes